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Abstract 
            Riboswitches are a broad class of RNA cis regulatory elements that enable controlled 
regulation of both mRNA transcription and translation. In E. faecalis, the SAM-III riboswitch 
responds to concentrations of S-adenosyl methionine (SAM) in order to regulate translation of 
the metK gene product, SAM synthetase. Following structural identification of a cryptic pocket 
in this structure, a fluorescent RNA assay detected binding of L-homocysteine and several 
structural analogs to this riboswitch. The binding responses of these ligands indicate they bind in 
a pocket distinct from the known SAM binding pocket. If further research can identify specific 
binding interactions that occur in the cryptic pocket, then the SAM-III riboswitch of E. faecalis 
will be the first example of a riboswitch capable of dual allosteric regulation at two distinct sites.  
  
Introduction 
RNA serves multiple roles within cellular environments related to genetic expression and 
regulation. Perhaps the most familiar role of RNA is as the primary messenger of genetic 
information in the form of mRNA. Other roles include rRNA in ribosomal structure and tRNA 
that transfers amino acids during protein synthesis. However, in recent years it has been shown 
that RNA has crucial regulatory roles in genetic expression as well. As the regulatory functions 
of RNA have been researched, complex RNA structures capable of allosteric regulation were 
discovered and deemed 
“riboswitches” in 20021-3. Much like 
proteins, these complex structures are 
organized into primary, secondary, 
and tertiary structural levels with the 
primary sequence determining folding 
patterns in higher structural levels. 
The primary sequence of RNA is the 
exact order of nucleic acid bases 
encoded during transcription. During 
transcription, this primary sequence 
can lead to the formation of a 
secondary structure by engaging in 
complementary base pairing. Then, at 
the tertiary structural level, this 
secondary structure can fold to form 
three-dimensional helices that contain 
ligand-specific binding pockets4. Instead of directly binding target genes to alter transcription 
initiation, riboswitches bind allosteric ligands to control transcriptional and pre-translational 
genetic expression. To affect these changes, ligands induce a specific conformational change 
within the riboswitch structure upon binding. In transcriptional regulation, the ligand promotes 
the formation of either a termination loop that halts transcription or anti-termination loop that 
prevents transcription from stalling. Meanwhile, in translational regulation, conformational 
changes alter the accessibility of the Shine-Dalgarno sequence to ribosomal binding5 (Figure 1). 
If this key recognition point for ribosomal subunits is hidden within the tertiary structure of the 
riboswitch, translation initiation will fail to occur and no products of the specific mRNA 
transcript will be produced. While riboswitch function has primarily been characterized as a 
chemical dependent switch in prokaryotic organisms, eukaryotic riboswitches also exist and 
exhibit more complex behavior involving transcript splicing due to the presence of introns and 
exons6. This process allows both prokaryotic and eukaryotic organisms to exert highly specific 
control over gene expression by responding to specific ligand concentrations prior to translation. 
In this particular study, the SAM-III riboswitch of E. faecalis was probed to determine if 
cryptic pocket binding existed within the known structure. Within E. faecalis, the SAM-III 
riboswitch functions as a negative feedback loop to prevent translation of the metK gene 
transcript, which is responsible for the translation of the SAM synthetase enzyme7. SAM 
synthetase catalyzes the conversion of L-methionine and ATP to SAM (Table 1), which is an 
important methyl donor within the cell and is often involved in processes such as DNA 
methylation and lipid synthesis8. Upon SAM 
binding the known riboswitch pocket, the 
Shine-Dalgarno sequence is made inaccessible 
to the ribosome by a conformational change in 
the riboswitch structure (Figure 1). The SAM-
III riboswitch of E. faecalis is well 
characterized with SAM binding in vitro at an 
approximate L1/2 of 0.85 µM in a well-defined 
pocket near the top of the characteristic “Y” 
structure of the folded RNA transcript9. 
However, through use of the fpocket software 
in the Weeks Lab, a cryptic pocket was 
identified within the stem of this structure. This 
pocket was cryptic by nature of being 
identified solely through computational 
modeling and was not definitively known to 
exist or bind any ligands prior to this study. 
The software identifies pockets based on 
physical dimensions, and the cryptic pocket 
was assigned a higher priority than the known SAM binding pocket due to a larger volume and 
more pocket-like structure (Figure 2). This seemed indicative of this pocket potentially binding a 
ligand, and a recent study by Smith et al. provided the first idea of what the identity of the 
binding ligand may be. In their study, Smith et al. demonstrated that L-methionine decreases 
metK RNA translation on levels comparable with SAM10. This led to the initial hypothesis that 
L-methionine was likely the correct ligand to bind within this cryptic pocket. However, there 
would later prove to be complications with this initial hypothesis. 
In this study, a 2-aminopurine hybrid assay was used to probe the SAM-III riboswitch of 
E. faecalis to identify and characterize binding in the cryptic pocket. The assay receptor was 
constructed of two half-templates of the SAM-III riboswitch; RNA2AP which ran from base 
G13-U46 with a 2-aminopurine fluorescent modification at the A29 site, and RNAComp from 
base G47-C106 (Figure 1). Smith et al. previously demonstrated that SAM binding to this 
receptor will lead to fluorescent quenching10, and it was theorized that binding in the cryptic 
pocket would also induce a similar response. The 2-aminopurine modification is quenched when 
bases surrounding the fluorescent tag are structurally altered to constrain this modified nucleic 
acid. It was thought that if a ligand bound the cryptic pocket, it would constrain the fluorescent 
tag to induce a quenching response as well. Using this method, L-homocysteine appears to be the 
primary binding ligand for the cryptic pocket, although L-methionine, L-cysteine, and L-acetyl 
methionine may also bind under certain conditions. These results indicate the presence of a 
cryptic binding pocket within the riboswitch structure that demonstrates a high level of structural 
specificity. These results are a preliminary indicator that the SAM-III riboswitch of E. faecalis is 
capable of dual allosteric regulation at distinct sites. 
 
  
Materials and Methods 
RNA sequences: The following two RNA half-templates of the E. faecalis metK gene were 




The first RNA template (RNA2AP) consisted of bases G13 to U46 and with a fluorescent 2-
aminopurine mutation at the A29 site that was excited at 310 nm. The second RNA template 
(RNAComp) consisted of bases G47 to C106 (Figure 1). 
2-aminopurine hybrid assay receptor: The RNA samples obtained from Dharmacon were 
suspended in TE buffer (10 mM Tris-HCl pH=7.5, 1 mM EDTA) with RNA2AP at 100 µM and 
RNAComp at 87 µM. The two RNA halves (RNA2AP and RNAComp) were combined at 2 µM 
RNA2AP with 2.3 µM RNAComp in 1x transcription buffer (20 mM Tris-HCl, pH=8.0, 20 mM 
NaCl, 10 mM MgCl2, 0.1 mM EDTA). The two strands were then annealed by heating to 68°C 
for 3 minutes followed by slow cooling back to 22°C in a dark box to allow for hybridization to 
occur.  
Receptor quenching verification: In 300 mL reaction volumes, the following samples were 
prepared: 1.5 µM RNA2AP, 1.5 µM RNA2AP with 60 µM SAM, 1.5 µM RNA2AP annealed 
with 1.75 µM RNAComp, and 1.5 µM RNA2AP annealed with 1.75 µM RNAComp with 60 µM 
SAM. Then, the samples were excited at 310 nm with fluorescence measured perpendicular to 
the excitation beam over 325-400 nm.  
Binding: Twofold ligand dilutions were performed on ice in 200 µL reaction tubes. After 50 µL 
of concentrated ligand solution was pipetted into the first tube, each following tube received 50 
µL of stepwise diluted 
ligand solution. 50 µL of 
nuclease free water was 
pipetted into the last tube 
to establish a signal for 
no ligand interaction. 
Once each reaction tube 
contained 50 µL of 
ligand solution, 50 µL of 
hybrid RNA receptor 
solution was pipetted 
into the tube and mixed 
well. This led to each 
tube containing 100 µL 
of solution: 50 µL of the 
given ligand 
concentration as well as 
50 µL of hybrid RNA receptor. After mixing, the RNA receptor solution was at 1 µM RNA2AP 
and 1.15 µM RNAComp.  
Spectrophotometry: All spectrophotometry measurements were taken on the UNC 
Macromolecular Interactions Facility’s SPEX Fluorolog-3: Research T-format 
Spectrofluorometer. The full 100 µL volume of each sample was pipetted into a 50 µL window 
fluorescence cuvette which was then loaded into the spectrofluorometer for scanning. The 
samples were excited at 310 nm with fluorescence measured perpendicular to the excitation 
beam over 360-380 nm. The maximum fluorescence emission at 370 nm was recorded and 




Assay verification: Following the 
initial research into the feasibility of a 
cryptic pocket, the hybrid receptor 
was tested to determine if it 
accurately identified ligand binding 
through fluorescent quenching. SAM 
was introduced at 60 µM 
concentration to ensure the binding 
sites were saturated, as the literature 
L1/2 for SAM binding is 0.85 µM9. As 
shown in Figure 3, when the 
RNA2AP strand alone was exposed 
to 60 µM SAM, no quenching 
response was observed. The 
construction of the hybrid receptor 
itself led to an approximate threefold decrease in fluorescent signal. However, when the hybrid 
riboswitch receptor was exposed to 60 µM SAM, the fluorescent signal was quenched by 40%, 
indicating that the receptor must be fully hybridized and be in the presence of a binding ligand 
for a quenching response to be observed. Next, to 
determine the utility of the assay for measuring L1/2 
values, twofold dilutions of SAM and S-adenosyl 
homocysteine (SAH) were performed from 0 µM-
1024 µM with the 1 µM hybrid receptor. For the 4 
independent SAM trials, the data was normalized to 
F1/F0 values based on the 0 µM data point to 
account for any mechanical variations in signal 
output. Similarly, the SAH experiments were 
normalized to F1/F0 values. However, the 2 
independent SAH trials were normalized to the 0.016 
µM value due to experimental inconsistencies at 
lower concentrations. All trials were plotted on a 
logarithmic scale as an average of the independent 
trials with error bars to 1 standard deviation. Figure 
4 shows that SAM follows the expected response 
curve for single site binding (𝑌 = 𝐵$%&×
()/+
()/+,[(./%01]
+ 𝐵𝑎𝑐𝑘𝑔𝑟𝑜𝑢𝑛𝑑) with consistent 
results that yield an L1/2 value of 1.1 µM. In this 
model, Y is the F1/F0 output, [Ligand] is the 
ligand concentration, Bmax is the amount of 
binding detected by the receptor, and the 
Background term accounts for any background 
signal noise present. When all of these terms are 
known, the equation can be used to identify the 
L1/2 value. Likewise, Figure 4 demonstrates that 
SAH also follows the expected response curve 
for single site binding with consistent results that 
yield an L1/2 value of 78 µM. 
L-methionine and analogs: L-methionine 
displayed dual quenching responses in 10 
independent twofold dilutions performed from 0 
µM-1024 µM with the 1 µM hybrid receptor 
(Figure 5). Due to the distinct dual nature of 
these responses, the 6 trials that displayed the 
quenching response are plotted as a separate 
average from the other 4 trials that displayed 
no quenching. Ligand stock age and the 
potential presence of contamination seemed 
to have no effect on these results. Fitting the 
results obtained from the hybrid assay to a 
one site binding equation, the L1/2 value for 
L-methionine was measured at 0.014 µM. 
Additionally, 2 independent trials of the L-
methionine structural analogs L-cysteine and 
L-acetyl methionine demonstrated a similar 
dual binding response. A L1/2 value of 0.0046 
µM was measured for L-acetyl methionine while 
L-cysteine did not present a stable enough 
response to calculate a L1/2 value from. (Figure 6) 
The oxidative degradation product methionine 
sulfoxide did not demonstrate a binding response. 
(Figure 7) All trials were normalized to F1/F0 
values and plotted on a logarithmic scale as an 
average of the independent trials with error bars to 
1 standard deviation. 
L-homocysteine and analogs: L-homocysteine 
displayed a singular binding response in 4 
independent trials of twofold dilutions from 0 µM-
1024 µM with the 1 µM hybrid receptor (Figure 
8). Despite a 5-month gap between trials, 
consistent results were continually observed. Fitting the results obtained from the hybrid assay to 
a one site binding equation, the L1/2 value for L-homocysteine was measured at 0.0038 µM. 
None of the L-homocysteine analogs (Table 1) showed a quenching response in their respective 
sets of 2 independent trials performed from 0 µM-1024 µM with the 1 µM hybrid receptor 
(Figure 9). All trials were normalized to F1/F0 values and plotted on a logarithmic scale as an 




Experiments measuring the quenching response of the hybrid assay demonstrated that the 
1 µM receptor accurately identified ligand binding as well as providing reasonable 
measurements of L1/2 values. As SAM is known to bind the SAM-III riboswitch of E. faecalis 
with a L1/2 value of 0.85 µM9 to inhibit metK translation, it was initially chosen to validate the 
assay function through a series of ligand dilution tests. These experiments verified that the 
receptor must be fully hybridized to bind SAM and that quenching the receptor with SAM led to 
an approximate 40% decrease in fluorescence (Figure 3). To further determine the utility of the 
receptor for measuring L1/2 values, SAM and SAH were both used in ligand dilution trials to 
measure the concentration dependent response of the receptor. SAH is also known to bind the 
SAM-III riboswitch with a L1/2 value of approximately 85 µM9. The results of these experiments 
(Figure 4) demonstrated a single site binding response for both ligands, with a L1/2 value of 1.1 
µM being measured for SAM and an L1/2 value of 78 µM being measured for SAH. Compared to 
the literature values9, these are both reasonable estimates of the L1/2 values for their respective 
ligands. These results indicate the assay is a useful tool for both identifying ligand binding and 
measuring binding affinities within the SAM-III riboswitch of E. faecalis. The primary limitation 
to this approach is that the pocket must be identified correctly and binding must induce a 
conformational change to detect a response. Additionally, the fluorescent tag must be placed in a 
region that detects conformational changes without interfering with binding.  
Following the validation of the assay, a series of two-fold dilutions were performed to 
investigate if any of the selected compounds would bind the cryptic pocket within the stem of the 
SAM-III riboswitch. A previous study by Smith et al. demonstrated that L-methionine reduces 
metK translation on a level comparable to SAM regulation10, prompting the initial hypothesis 
that L-methionine was likely to be the correct ligand. Smith et al. believed that conversion of L-
methionine to SAM within their system was responsible for the result, but this may also point 
towards the existence of a second binding ligand within the SAM-III riboswitch. However, these 
original predictions were complicated by the results shown in Figure 5 as L-methionine 
demonstrated two distinct responses: a binding response with a L1/2 value of 0.014 µM along 
with a non-binding response. Further complicating this original hypothesis, L-cysteine and L-
acetyl methionine both showed the same dual response as L-methionine, with L-acetyl 
methionine having a measured L1/2 value of 0.0046 µM. The L1/2 of L-cysteine could not be 
calculated using the one site binding equation due to the instability of the data. Instead of a single 
ligand binding to the SAM-III riboswitch with a singular response, three ligands were identified 
to bind with dual responses. Initially, contamination was thought to be a potential cause of the 
observed dual responses, but when the raw data was analyzed, all trials demonstrated a consistent 
fluorescent signal, indicating the RNA receptor maintained structural integrity throughout the 
trials and was not subject to degradation by any foreign RNAse enzymes. To investigate the role 
of oxidative degradation in these results, the primary oxidative degradation product of L-
methionine, methionine sulfoxide11, was also tested. As several fresh L-methionine stocks 
displayed a non-binding response, the lack of a binding response in methionine sulfoxide 
allowed oxidative degradation to be ruled out as a reason for the non-binding response of L-
methionine.  
The dual nature of L-methionine, L-cysteine, and L-acetyl methionine responses 
prompted further research into the SAM synthesis cycle to determine if a ligand more 
metabolically suited to regulate the SAM-III riboswitch would bind the cryptic pocket. 
Metabolically, L-methionine is somewhat of an enigma if it binds the riboswitch to induce a 
decrease in metK translation, as the metK gene encodes for the SAM synthetase enzyme that 
converts L-methionine and ATP into SAM7 (Figure 10). However, L-homocysteine would be a 
more metabolically suited binding ligand due to the role it plays in the SAM synthesis cycle. As 
a downstream byproduct from SAM 
that does not participate directly in 
the SAM synthesis reaction, L-
homocysteine would be well suited to 
regulate translation of the metK gene 
as a form of a negative feedback loop, 
as shown in Figure 10. It is also 
known from previous studies that 
SAM inhibits translation of SAM 
synthetase and activates cystathionine 
synthase12 to conserve cellular 
resources and reduce toxic levels of 
SAH by shifting metabolism towards 
the TCA cycle (Figure 10). 
Cystathionine synthase converts L-
homocysteine to cystathionine, which 
after several more reactions enters the 
TCA cycle as succinyl CoA to 
generate ATP13. However, it would 
be useful for the cell to have a means to shift the SAM synthesis cycle towards protein synthesis 
to ensure that L-methionine levels remain sufficient for tRNA charging14. L-homocysteine could 
fill this role by binding the cryptic pocket to inhibit metK translation even when the local 
concentration of SAM is too low to accomplish this. Additionally, L-homocysteine could 
streamline the metabolic shift towards protein synthesis by inhibiting metK translation without 
also activating cystathionine synthase. 
When L-homocysteine was 
tested, it contrasted the dual 
responses of L-methionine, L-
cysteine, and L-acetyl methionine by 
displaying a distinct singular binding 
response in every trial with a L1/2 
value of 0.0038 µM. This result 
indicates that the riboswitch is 
capable of consistently binding L-
homocysteine as a second ligand at 
low concentrations. Further testing 
indicated that the riboswitch is also 
capable of differentiating between the 
L/D stereoisomers of homocysteine, 
which is a feature common in 
biological systems as all natural 
amino acids occur in the L conformation. The lack of a binding response by the analogs L-
norvaline and L-homoserine indicates the importance of the sulfur group in binding interactions 
and that the slight difference between oxygen and sulfur is enough to prevent binding. 
Interestingly, the binding responses of L-methionine, L-cysteine, L-acetyl methionine, and L-
homocysteine are nearly identical. While the fluorescent signal of the receptor was quenched by 
approximately 20% less in these trials than the responses displayed by SAM and SAH, the 
similarities in responses indicate that these ligands are likely binding at the same site and causing 
similar changes in the structural conformation of the riboswitch (Figure 11). As it is already 
known that the SAM binding pocket does not recognize the methionine moiety of SAM9, this 
provides strong evidence that binding is occurring in the cryptic pocket. If these ligands are truly 
binding in the cryptic pocket, then the SAM-III riboswitch of E. faecalis is the first riboswitch 
system to be discovered capable of dual allosteric regulation at distinct sites. 
A potential model to explain these behaviors is based on the kinetic factors associated 
with each ligand and the structural features of the pocket. As L-homocysteine displays a 
consistent binding response, it is clearly the preferred binding ligand of the system. However, L-
methionine and L-cysteine have high levels of structural similarity to L-homocysteine which 
could account for their dual responses (Table 1). L-methionine is possibly capable of binding the 
pocket because the electronegativity of the sulfur group is capable of overcoming the steric 
hindrance of the terminal methyl group. While L-cysteine lacks such steric hindrance, the shorter 
aliphatic chain could place the thiol group farther away from critical RNA bases involved in 
binding, which leads to unstable binding. L-acetyl methionine contains the largest steric bulk of 
all the tested ligands, and as such it was not expected to have a binding response at all (Table 1). 
However, the dual response of L-acetyl methionine may be due to the riboswitch showing a 
preference for binding L-homocysteine over D-homocysteine. If D-homocysteine orients the 
amine group towards the inside wall of the pocket, it may cause enough steric hindrance to 
prevent binding. However, if L-acetyl methionine orients the modified amine group towards the 
outside of the pocket, it may cause little steric hindrance to binding interactions, thus still 
allowing it to bind given certain kinetic conditions. Under this model, it would be expected to see 
intermediate responses as well, but the data suggests that there may exist a critical incubation 
time point after which the riboswitch is highly likely to bind non-L-homocysteine ligands as 
well. None of the trials were measured on a time dependent basis, but further research into time 
dependent binding may elucidate further details of this proposed mechanism. Another potential 
model to explain this behavior is based on the ability of the riboswitch to adopt multiple 
conformations. When SAM is not bound to the riboswitch, it assumes a conformation favorable 
to translation (ON) while SAM binding induces a conformational change to prevent translation 
(OFF). However, a study by Lu et al. identified that the riboswitch can occupy a third state 
(Ready), with the energy gap between the ON and Ready states being less than 3.2 kcal/mol15. 
Further investigation into the structure of this intermediate state by Wilson et al. indicated that 
the intermediate structure may be more favorable to cryptic pocket binding than the ON state16. 
While the presence of an intermediate state seems to have no effect on L-homocysteine binding, 
the structural differences between states may account for the dual responses of L-methionine, L-
cysteine, and L-acetyl methionine. While both of these models require further testing along with 
the investigation of other potential models, L-methionine, L-cysteine, and L-acetyl methionine 
all appear to bind the riboswitch given sufficient conditions, while L-homocysteine is the 




The results of this study indicate that cryptic pocket binding exists within the SAM-III 
riboswitch of E. faecalis and that this may be the first known riboswitch system capable of dual 
allosteric regulation. Furthermore, the binding site exhibits high structural specificity with a clear 
preference for L-homocysteine, although other structural analogs may bind given certain kinetic 
parameters. The hybrid receptor used to probe the SAM-III riboswitch demonstrates utility for 
identifying binding responses and for measuring binding affinities. A major limitation of this 
study is the inability of the assay to distinguish where precise binding interactions occurred. The 
assay was highly effective at identifying binding, but until further experiments can be conducted 
with SHAPE/MAP or FragJump techniques, it cannot be confirmed that binding occurs in the 
cryptic pocket. Further research into riboswitch cryptic pockets could potentially characterize the 
exact binding interactions measured in this study along with discovering other riboswitch 
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